| Fund ID | 805-3947357215 |
| Fund type | Hedge Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | Yes |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 100% |
| Owned by the adviser or related persons | 8% |
| Owned by funds of funds | 10% |
| Owned by non-U.S. persons | 0% |
| Fund | Type | Gross assets |
|---|---|---|
| Gt Partners, L.P. | Hedge | $2.86B |
| Gt Global Hedge, L.P. | Hedge | $1.81B |
| Gt Offshore Fund, Ltd. Class a | Hedge | $810.8M |
Gt Biotech Fund, LP reports $256.8 million in gross assets, among the top 26% of private funds by size.
The stated minimum investment is $250,000.
Gt Biotech Fund, LP is managed by Gerber/Taylor Management LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.